Heading to
#TCT2026 in San Diego? Join
$BEAT on Sunday when Dr. Graham Nichol of the University of Washington will present results from ALIGN-ACS, our pilot study comparing HeartBeam’s credit card-sized device with the standard 12-lead ECG in emergency room patients with potential heart attack symptoms.
📍 “Detection of Acute Coronary Syndrome by a Credit Card-Sized 3-Lead Device Versus Standard 12-Lead ECG in Emergency Department Patients”
🗓 Sunday, November 1, 2026
🕐 1:00 to 1:50 PM PT | Station 7
We look forward to sharing the results!
The HeartBeam System is FDA cleared for arrhythmia assessment only. Its use for heart attack assessment is investigational and not FDA cleared.